Vyara Tiles Limited
₹ 0▲0.00%(0.00)
About the company
Vyara Tiles Limited, established in 1989 and headquartered in Surat, Gujarat, is a leading manufacturer of concrete paving blocks, flagstones, and landscaping tiles used in residential, commercial, and public infrastructure projects. With over three decades of industry experience, the company has built a strong reputation for delivering durable, high-quality products that support modern urban development and landscaping needs across India.
The company manufactures and supplies a wide range of concrete paving and landscaping solutions under its Vyara Tiles and Freeform brands, catering to infrastructure developers, contractors, government projects, and private customers. Originally incorporated as a private limited company, Vyara Tiles was converted into a public limited company in 2024 as part of its growth strategy and is preparing for its Initial Public Offering (IPO) on the BSE SME platform. With a focus on quality manufacturing, product innovation, and expanding market reach, Vyara Tiles Limited is well-positioned to capitalize on the growing demand for urban infrastructure and sustainable construction solutions in India.
Fundamentals
Valuation
- 52 week high
- —
- 52 week low
- —
- P/B ratio
- 0
- Debt to equity
- 0.92
- ROE (%)
- 27.14%
- Book value
- ₹25.93
- Face value
- ₹10
- Valuation
- —
Registry
- ISIN number
- INE0Y5C01023
Figures in lk ·
Financials
| P&L Statement | 2023 | 2024 |
|---|---|---|
| Revenue | 8227 | 9357 |
| EBITDA | 1326 | 1724 |
| OPM | 16.12 | 18.42 |
| PBT | 616 | 1194 |
| PAT | 447 | 859 |
| EPS | 22.39 | 43.04 |
Shareholding Pattern
Leadership
Frequently asked questions
Common questions on Vyara Tiles Limited—tap a row to read the answer.
Q.1What does Vyara Tiles Limited do?
Vyara Tiles Limited is an Indian manufacturer of concrete paving blocks, flagstones, and landscaping tiles used in residential, commercial, and infrastructure projects. The company supplies durable paving and landscaping solutions under its Vyara Tiles and Freeform brands, serving contractors, developers, government bodies, and institutional customers.
Q.2What should investors consider before investing in Vyara Tiles Limited?
Before investing, it is advisable to evaluate the company's financial performance, manufacturing capabilities, product portfolio, customer base, industry demand, management team, valuation, growth strategy, and IPO plans. Understanding these factors can help investors make informed long-term investment decisions.
Q.3What are the risks of investing in Vyara Tiles Limited unlisted shares?
Like all unlisted investments, Vyara Tiles Limited shares carry risks such as lower liquidity, limited public information, price fluctuations, and uncertainty around the timing of a future listing. Investors should conduct thorough research and invest according to their financial goals and risk appetite.
Q.4Is Vyara Tiles Limited planning an IPO?
Yes. Vyara Tiles Limited has announced its intention to launch an Initial Public Offering (IPO) and list its shares on the BSE SME platform. However, the listing will depend on regulatory approvals, market conditions, and the company's final IPO schedule.
Q.5How is the price of Vyara Tiles Limited unlisted shares determined?
The price of Vyara Tiles Limited unlisted shares is influenced by several factors, including the company's financial performance, earnings potential, business growth, investor demand, market sentiment, and recent transactions in the unlisted shares market.
Trending shares
High-demand unlisted opportunities currently available for trade.
From the blog
Notes on unlisted markets, execution hygiene, and how we think about risk—no hype, no ticker spam.

APTUS PHARMA IPO
Aptus Pharma Limited rolled out its 100% book-built BSE SME public offering worth ₹13.02 Crore. Review crucial parameters for retail investors, featuring the ₹65–₹70 price band, working capital allocations, and an evaluation of its contract-manufacturing partner model.

NEPHROPLUS (NEPHROCARE HEALTH SERVICES) IPO
Explore the Neochem Bio IPO, including issue details, business strengths, risks, and investment analysis.

APOLLO TECHNO INDUSTRIES IPO
Apollo Techno Industries Limited has announced its public offering details. Explore the essential investment parameters for retail and institutional bidders, highlighting the fixed price band, lot structure, key market deadlines, and an overview of its industrial manufacturing footprint.

NEOCHEM BIO IPO
Explore the Neochem Bio IPO, including issue details, business strengths, risks, and investment analysis.

ANONDITA MEDICARE IPO
Anondita Medicare Limited rolled out its 100% book-built SME public offering worth ₹69.50 Crore on the NSE SME platform. Dig into the critical parameters for investors, highlighting the ₹137–₹145 price band, key working capital objectives, and an analysis of its flagship brand 'COBRA' within the growing sexual wellness market.

NEPTUNE LOGITEK IPO
Explore the Neptune Logitek IPO, including issue details, business strengths, risks, and investment analysis.
